A Phase IB/II Single-arm Study of M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas
Phase of Trial: Phase I/II
Latest Information Update: 17 Apr 2018
At a glance
- Drugs Gemcitabine (Primary) ; MSB 0011359C (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2018 Planned initiation date changed from 16 Apr 2018 to 18 Apr 2018.
- 10 Apr 2018 Planned initiation date changed from 27 Mar 2018 to 16 Apr 2018.
- 22 Mar 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 7 Mar 2018 to 27 Mar 2018.